Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-19

Clinical Trial Update: Comparison of Two Pen Systems in Patients With Diabetes Treated With Insulin [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing two insulin pen delivery systems in patients with diabetes treated with insulin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED